CRP and COVID-19: A persistent inflammatory state and immune activation, characterized by increased blood levels of the inflammatory cytokines–TNFα, IL-6, IL-1 and CRP, although not specific to COVID-19 [39], may induce apoptosis with secondary endothelial dysfunction and may increase intrahepatic clot development risk.